LMR Partners’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-100,000
Closed -$987K 1519
2022
Q3
$987K Hold
100,000
0.02% 745
2022
Q2
$983K Hold
100,000
0.02% 764
2022
Q1
$978K Hold
100,000
0.01% 835
2021
Q4
$980K Hold
100,000
0.01% 720
2021
Q3
$973K Hold
100,000
0.01% 658
2021
Q2
$968K Buy
+100,000
New +$972K 0.01% 551

LMR Partners's SHAC Position: Q4 2022 in Review

LMR Partners sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q4 2022, closing a stake of 100,000 shares — an estimated $987K sold.

LMR Partners first reported a position in SHAC in Q2 2021 and held it in 6 quarters. The position peaked at $987K in Q3 2022. 0 funds tracked by Wall St. Rank hold SHAC as of Q4 2022.

  • LMR Partners reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • LMR Partners sold 100,000 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q4 2022, an estimated $987K.
  • LMR Partners first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q2 2021 and held it in 6 quarters.
  • LMR Partners's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $987K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q4 2022.

Based on LMR Partners's 13F filing for Q4 2022, filed 14 Feb 2023.